The expression of NECTIN4 is generally low in normal tissues, whereas it increases in various malignant tumors; its association with tumor progression has been reported among breast, urothelial, pancreatic, lung, and ovarian cancers [22,23,24]. Here, NECTIN4 is linked to neoplasm.